11/23/2020 09:52 GMT — AstraZeneca’s ‘Oxford’ vaccine 70% effectiveAccording to a recent press release, the experimental COVID-19 vaccine developed by AstraZeneca and Oxford University prevents just over 70% of people from developing COVID-19.
Although this is lower than the Pfizer and Moderna vaccines, using a different dosing regimen may increase the protection to 90%.The recent announcement is based on data from 24,000 participants in three countries.
Importantly, the Oxford vaccine is more cost effective to produce and easier to store and transport than the Pfizer and Moderna vaccines.The so-called Oxford vaccine trial tested two dosing regimens:Prof.